Business PR Newswire Senhwa Biosciences’ CX-5461 Teams Up with Global PD-1 Leaders to Enter the Immunotherapy Arena, Targeting Multi-Billion Dollar Global Market rvrisingnetwork September 16, 2025September 20, 2025 TAIPEI and SAN DIEGO, Sept. 16, 2025 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492, “Senhwa”)…
